ArticleCentral-European journal of immunology2020

CCR6 blockade on regulatory T cells ameliorates experimental model of multiple sclerosis.

Izabela Jatczak-Pawlik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.